WCA
MRK icon

Waratah Capital Advisors’s Merck MRK Stock Holding History

Waratah Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,024
Closed -$203K – 185
2015
Q4 		$203K Buy
+4,024
New +$203K 0.04% 138

Other funds holding MRK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Waratah Capital Advisors's MRK Position: Q1 2016 in Review

Waratah Capital Advisors sold out of Merck (MRK) in Q1 2016, closing a stake of 4,024 shares — an estimated $203K sold.

Waratah Capital Advisors first reported a position in MRK in Q4 2015 and held it in 1 quarter. The position peaked at $203K in Q4 2015. 1,745 funds tracked by Wall St. Rank hold MRK as of Q1 2016.

  • Waratah Capital Advisors reported no remaining Merck position as of Q1 2016 after selling out during the quarter.
  • Waratah Capital Advisors sold 4,024 Merck shares in Q1 2016, an estimated $203K.
  • Waratah Capital Advisors first reported a position in Merck in Q4 2015 and held it in 1 quarter.
  • Waratah Capital Advisors's Merck position peaked at $203K in Q4 2015.
  • 1,745 funds tracked by Wall St. Rank held Merck as of Q1 2016.

Based on Waratah Capital Advisors's 13F filing for Q1 2016, filed 4 May 2016.